COL1A1 and metabolic dysfunction-associated steatohepatitis: SAR (3 mg/kg, oral) also mitigate the expression of pro-inflammatory genes (Tnfα, Mcp-1), fibrotic genes (α-SMA, Col1a1 and Ctgf), and collagen area in CDAHFD induced NASH model 137.